Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alzinova presents preclinical data on Alzheimer disease candidates at the AAIC conference

Alzinova AB (publ) (FN STO: ALZ), is today presenting data on the monoclonal antibody, ALZ-201, at the Alzheimer’s Association International Conference (AAIC) held in Denver, USA and online. The preclinical data support the continued development of Alzinova’s lead candidate, ALZ-101, which is further in development and is expected to enter the clinical phase with a Phase 1b study in Alzheimer's patients during the third quarter of 2021.Dr. Anders Sandberg, Chief Scientific Officer at Alzinova, is presenting the scientific poster entitled: A novel Aβ42 oligomer-specific antibody ameliorates

Aspire Global Accelerates Operations in the US by Appointing Quincy Raven as Managing Director

Aspire Global  has taken another important step in expanding its business in the US by appointing experienced executive Quincy Raven as Managing Director of Aspire Global US.The US is one of Aspire Global’s prioritized markets in which the company foresees significant growth opportunities. As the Managing Director of Aspire Global US, Quincy Raven will be instrumental in leading and executing on Aspire Global’s growth strategy for the US gaming market. Quincy brings key market insights and expertise to the company’s management team with over 20 years of experience

Buybacks of shares in Alfa Laval during week 29 2021

During the period July 19 – July 23, 2021, Alfa Laval AB (publ) (LEI code: 549300UCKT2UK88AG251) has repurchased in total 109,481 own shares (ISIN: SE0000695876) as part of the share buyback program initiated by the Board of Directors in order to secure optimized capital structure.The share buybacks form part of the SEK 2 billion share buyback program, which Alfa Laval announced on April 27, 2021. The share buy-back program, which runs between April 28, 2021 and April 25, 2022, is being carried out in accordance with the EU Market Abuse Regulation (MAR) and the Commission Delegated

Ahlstrom-Munksjö to restart existing saturator in its Turin plant in Italy to support demand for high performance filtration media globally

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE July 26, 2021 at 16:00 EEST Ahlstrom-Munksjö will restart one of its saturator in its Turin plant in Italy to support strong demand for high performance filtration media.  “Based on current strong customer demand, we see a need to expand our saturating capacity,” said Giuseppe Costa, VP Filtration EMEA and APAC. “We have evaluated various options and came to the conclusion that restarting the saturator we already have in place in Turin is the quickest and most reliable way to bring qualified capacity to the marketplace in a very short period,” he

Danish Reward platform just gave away 2 BILLIONTH point

Ekstrapoint is the best free-to-play loyalty platform in the Igaming marketCopenhagen, 26.07.2021 – Ekstrapoint.com, the first and only loyalty and reward platform in the iGaming industry, has just recorded its 2 BILLIONTH point rewarded to a user of the platform.  With more than 100.000 happy players across several countries and an astonishing Trustpilot rating of 4,8 out of 5 based on hundreds of reviews place Ekstrapoint.com as the best loyalty reward platform in the world, according to the members of the gaming platform.  The record 2 billionth point was delivered after

Clinical results (5 yrs) for Episealer® accepted for presentation at the ISAKOS 2021 Global Congress

Episurf Medical (Nasdaq: EPIS B) today announces that an abstract with results from a Swedish multicentre clinical study with 5 years’ follow-up of Episealer® Knee patients has been accepted for presentation at the upcoming ISAKOS 2021 Global Congress. The abstract, “Good Subjective Outcome And Low Risk Of Revision Surgery With A Novel Customized Metal Implant For Focal Femoral Chondral Lesions At A Minimum Of Five Years Follow-Up“, will be presented by Associate Professor Anders Stålman, Capio Artro Clinic, Stockholm, Sweden. ISAKOS (International Society of Arthroscopy, Knee Surgery

Vice Chair of the Neles Board of Directors Perttu Louhiluoto resigns, Anu Hämäläinen appointed as the new Vice Chair

Neles Corporation, Stock exchange release, July 26, 2021, at 3:00 p.m. EESTPerttu Louhiluoto, a member of the Board of Directors of Neles Corporation, has announced his resignation from the Board as of today. The reason for the resignation is his election as the President and CEO of a UK-based flow control company.The Shareholders' Nomination Board of Neles has assessed that the Board will remain functional after Louhiluoto’s resignation, and that the Board's composition will continue to meet the requirements set out in the Articles of Association."Perttu Louhiluoto was elected as the

DanCann Pharma A/S has carried out a directed issue of shares of approx. DKK 6.375 million and warrants, in combination with obtaining a loan facility of SEK 13.7 million

COPENHAGEN, Denmark, 26 July 2021 - DanCann Pharma A/S (Publ) (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announces that based on the resolutions to issue shares and warrants on the Extraordinary General Meeting on 23 July 2021, the Company has issued a total of 1,702,339 new shares at price of DKK 3.745 per share (which corresponds to the closing price as of 22 July 2021), where the Board of Directors and Executive Management participate, which adds the Company a total of DKK 6,375,259.555, and a total of 1,702,339 new warrants, this in combination with obtaining a loan facility

ContextVision – Mandatory notification of trade – primary insider

STOCKHOLM – July 26, 2021 – Olof Sandén, Chairman of the Board of ContextVision, has on July 6, 2021 purchased 500 shares in ContextVision AB at an average price of NOK 18.00 per share. After the transaction, Mr Sandén holds a total of 3,000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision ABISIN number: SE0014731154Stock ticker: CONTXName of primary insider: Olof SandénRelation to listed entity: Chairman of the Board of

FREYR Battery Chooses Mpac Lambert for Supply of Battery Cell Assembly Equipment Package to Customer Qualification Plant

LUXEMBOURG, July 26, 2021, FREYR Battery (“FREYR”), a developer of clean, next-generation battery cell production capacity, has signed a contract with Mpac Lambert for the supply of the casting and unit cell assembly equipment package to the battery cell production line at FREYR’s Customer Qualification Plant (“CQP”) in Mo i Rana, Norway. Preparatory work on the facility is already ongoing with a targeted start of initial operations in the second half of 2022. Mpac Lambert, a UK-based developer of automation and mass production solutions, was prequalified to participate in the

Croatia is currently the safest tourist destination in the Mediterranean

Stockholm, July 26, Croatia has the most favourable epidemiological compare to other countries in the Mediterranean. According to the European Center for Disease Prevention and Control (ECDC), the current average 14-day incidence rate per 100,000 inhabitants in Croatia is 33.7   Stockholm, July 26, Croatia has the most favourable epidemiological compare to other countries in the Mediterranean. According to the European Center for Disease Prevention and Control (ECDC), the current average 14-day incidence rate per 100,000 inhabitants in Croatia is 33.7 In general, Croatia has a

Staffs student joins global fight against plastic pollution

A Staffordshire University student plans to help recovery efforts in Sri Lanka after millions of plastic pellets washed up on its shoreline.Hannah Parkin never expected to go to university but after finding a passion for forensics she is taking her research skills across the world. She explained: “I didn’t do well in my GCSEs, so I’d gone back to college to get my Science and it was in college that I did Applied Science and Forensics and that’s where it all started.” Hannah has just completed a BSc (Hons) Forensic Investigation 

Peab builds hangar for surveillance airplanes in Evenes

Peab has been commissioned to build a hangar, warehouse, workshop and administration building at Evenes airstation for military flight surveillance airplanes.  The general contractor is Forsvarsbygg and the contract is worth around NOK 646 million.The groundwork on the hangar plot, which will house the surveillance airplane P-8, began in 2020 and was completed in July 2021. Peab’s contract comprises construction of a total of 21,500 m2 consisting of a hangar, warehouse, workshop and administration building. “As a local actor and community builder in northern Norway it’s fantastic to sign

SimCorp A/S – Share buyback program

Company Announcement no. 32/2021On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021. The following transactions have been executed under the program:          Date                 Number of shares

Wulff Group Plc’s Half-Year Financial Report for January 1–June 30, 2021

HALF-YEAR FINANCIAL REPORT  JULY 26, 2021 AT 10.45 A.M. This is a summary of Wulff Group Plc’s half-year financial report for January-June 2021. Wulff Group’s half-year financial report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi.  The acquisition boosted revenue and operating profit growth 1.4.–30.6.2021 BRIEFLY · Wulff became the market leader by acquiring workplace products and services expert Staples Finland Ltd and its Finnish parent company EMO Finland Ltd (hereinafter Wulff

Change in Wulff Group Plc's Group Executive Board

STOCK EXCHANGE RELEASE JULY 26, 2021 AT 10.40 A.M.Tomi Hilvo, CEO of Wulff Entre Ltd and a member of the Wulff Group's Executive Board, resigns and joins another company in August. Elina Pienimäki, CEO of Wulff Group Plc, Trond Fikseaunet, CEO of Wulff Supplies AB, Elina Hanén, CFO of Wulff Group Plc, Tarja Törmänen, Director of Communications and Marketing of Wulff-Group Plc, and Veijo Ågerfalk, CEO of Wulff Beltton, will continue as the members in the Wulff Group Executive Board. “I thank Tomi Hilvo for a good job at Wulff Entre. In a challenging market situation, we succeeded in

NPD Group leverages Cint to accelerate business process efficiencies

Global data and analytics company uses the Cint platform to adopt a streamlined approach to sample operations and data collectionStockholm, Sweden - 26 July 2021 -  The NPD Group , a leading provider of market information, will work with Cint , the global software leader in digital insights gathering, to help manage its sampling and data collection process. Cint will help improve the speed, scale and deliverability of NPD’s industry-leading market data to its customers.  With Cint’s Insight Exchange, NPD will have access to the world’s largest

Flowscape wins order in Switzerland

A consulting company based in Switzerland and Germany chooses Flowscape for room booking and workplace booking.The company decided to install Flowscape’s solution at their head office in Zurich, Switzerland. The company has several offices in Germany and Switzerland, and the plan is to install Flowscape in these offices as well. The order value is 10,900 Euro (SEK 115,000) with recurring income of 5000 Euro (SEK 55,000).  "The European market is now opening up after the pandemic. In many European countries, there is an important shift where employees will work more from home. The change

New Fazer autumn goodies make life sweet

Once again, Fazer's autumn releases promise memorable, delicious moments to those with a sweet tooth. Chocolate lovers will welcome the Karl Fazer Avec chocolate bar, as well as the smaller Fazer Moomin Maitosuklaa milk chocolate and tangy Karl Fazer Sitruunajugurtti lemon yoghurt bars. Exciting flavours will be offered by Tyrkisk Peber Choco and the new salty liquorice pastilles. Or how does Fazer Salmiakki Smoky Whiskey Flavoured salty liquorice sound to you?The perfect rendez-vous – Karl Fazer Avec 200 g  When the nights draw in, the authentic Karl Fazer Milk Chocolate, a long-time

New Clinical Study in Japan Shows Statistically  Significant Result in-hospital Rapid Induction of Cooling After Witnessed Shockable Out-Of-Hospital Cardiac Arrest

A new publication in Circulation Journal, https://pubmed.ncbi.nlm.nih.gov/34261843/[1], with statistically significant results on patients whose collapse to return of spontaneous circulation (ROSC) interval was delayed over 18 min after shockable out-of-hospital cardiac arrest (OHCA) with in-hospital rapid cooling by intravenous ice-cold fluids. The study was an analysis of collected data from 248 comatose survivors with ROSC who were treated with therapeutic hypothermia (34°C for 12–72 h) after witnessed shockable OHCA in Japan. A scientific presentation from Japan, investigating

Notification of trades

Reference is made to Aker BP's press release from 16 July 2021, where the company announced its plan to buy up to 500,000 own shares in connection with the company's employee share saving plan. In the period from 19 July to 23 July, the company purchased 500,000 shares at an average price of NOK 243.88, and the program is now completed. An overview of the transactions, and a detailed specification of each individual trade, are attached to this announcement and available at www.newsweb.no.  Following the completion of these transactions, Aker BP ASA owns a total of 1,003,294 own shares,

Admission of New Shares

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. 26 July 2021  EnQuest PLC  Admission of New Shares EnQuest PLC ("EnQuest", or the "Company") today announces that, pursuant to the Firm Placing and Placing and Open Offer (the "Capital Raising") announced on 30 June 2021, 190,122,384 New Ordinary Shares will be

Ultomiris recommended in EU for children with PNH

26 July 2021 07:00 BST Ultomiris recommended for approval in the EU by CHMP forchildren and adolescents with paroxysmal nocturnal haemoglobinuria Opinion based on results from Ultomiris Phase III trial that showed an established efficacy and safety profile with reduced treatment burden for children with PNH and their families   Alexion's Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for expanded use to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH). The Committee for Medicinal Products

Alimak Group’s EVP for Division BMU Mark Casey leaves the company

Mark Casey has decided to leave his role as EVP of the BMU Division. Cameron Reid, BMU Manager Europe will assume the role of Interim EVP. Mark joined the Alimak Group through the acquisition of Façade Access group and since 2018 he has led the BMU division. "I want to thank Mark for his commitment and contribution to our journey at Alimak Group during the last 3,5 years,” says Ole Kristian Jødahl, CEO Alimak Group. Mark Casey will remain available to support a smooth transition over the coming months. The recruitment process to find a permanent EVP for BMU Division will be initiated

There are no items matching the current filter
There are no more items matching the current filter
Back to top